Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Literature DB >> 30365392

ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Charles L Daley^1,2, Kenneth N Olivier³.

Abstract

Entities: Chemical

Mesh：

Substances：
Liposomes
Amikacin

Year: 2018 PMID： 30365392 PMCID： PMC7212798 DOI： 10.1164/rccm.201810-1901ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

11 in total

Review 1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors: David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal: Am J Respir Crit Care Med Date: 2007-02-15 Impact factor: 21.405

2. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors: Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal: Am J Respir Crit Care Med Date: 2012-02-03 Impact factor: 21.405

3. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

Authors: David E Griffith; Gina Eagle; Rachel Thomson; Timothy R Aksamit; Naoki Hasegawa; Kozo Morimoto; Doreen J Addrizzo-Harris; Anne E O'Donnell; Theodore K Marras; Patrick A Flume; Michael R Loebinger; Lucy Morgan; Luigi R Codecasa; Adam T Hill; Stephen J Ruoss; Jae-Joon Yim; Felix C Ringshausen; Stephen K Field; Julie V Philley; Richard J Wallace; Jakko van Ingen; Chris Coulter; James Nezamis; Kevin L Winthrop
Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405

4. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review.

Authors: Jakko van Ingen; Christine Y Turenne; Enrico Tortoli; Richard J Wallace; Barbara A Brown-Elliott
Journal: Int J Syst Evol Microbiol Date: 2018-09-19 Impact factor: 2.747

5. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.

Authors: Kenneth N Olivier; David E Griffith; Gina Eagle; John P McGinnis; Liza Micioni; Keith Liu; Charles L Daley; Kevin L Winthrop; Stephen Ruoss; Doreen J Addrizzo-Harris; Patrick A Flume; Daniel Dorgan; Matthias Salathe; Barbara A Brown-Elliott; Renu Gupta; Richard J Wallace
Journal: Am J Respir Crit Care Med Date: 2017-03-15 Impact factor: 21.405

ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Review 1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

2. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

3. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

4. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review.

5. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.

Review 6. Nontuberculous mycobacteria and associated diseases.

7. Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review.

Review 8. NTM drug discovery: status, gaps and the way forward.

9. Pulmonary tuberculosis apparently caused by the avian tubercle bacillus.

10. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010.

Review 1. Repositioning rifamycins for Mycobacterium abscessus lung disease.

Review 2. The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex.